Skip to main content
OpenTrials

Clinical trial condition

Gastroesophageal Junction Adenocarcinoma

Explore clinical trials studying Gastroesophageal Junction Adenocarcinoma. Study availability and eligibility vary by location and protocol.

131 public trials 41 recruiting studies
Refine in advanced search Browse all conditions

Gastroesophageal Junction Adenocarcinoma trial results

Completed

Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer

NCT04208958

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +28 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Pacific Hematology Oncology Associates San Francisco, California, United States
  • The Angeles Clinic and Research Institute - West Los Angeles Office Santa Monica, California, United States
View all 18 locations
View Trial Details
Completed

Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors

NCT04344795

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +41 more
Locations
  • University of Colorado Aurora, Colorado, United States
  • Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine Baltimore, Maryland, United States
  • Baystate Gynecologic Oncology Springfield, Massachusetts, United States
  • University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
View Trial Details
Completed

A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies

NCT04772989

Conditions
Advanced Solid Tumor, Blood Protein Disorders, Bronchial Neoplasms, +62 more
Locations
  • UCLA Department of Medicine - Hematology/Oncology Los Angeles, California, United States
  • Mayo Clinic Jacksonville - PPDS Jacksonville, Florida, United States
  • Goshen Health System Goshen, Indiana, United States
  • Holden Comprehensive Cancer Center Iowa City, Iowa, United States
View all 22 locations
View Trial Details
Completed

SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas

NCT03894618

Conditions
Adenocarcinoma, Anus Diseases, Anus Neoplasms, +68 more
Locations
  • The Sarah Cannon Research Institute Nashville, Tennessee, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Leuven Cancer Institute Leuven, Belgium
  • Princess Margaret Cancer Center Toronto, Ontario, Canada
View Trial Details
Completed

Tucatinib, Trastuzumab, Ramucirumab, and Paclitaxel Versus Paclitaxel and Ramucirumab in Previously Treated HER2+ Gastroesophageal Cancer

NCT04499924

Conditions
Adenocarcinoma Of Esophagus, Esophageal Adenocarcinoma, Gastric Adenocarcinoma, +1 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Arizona Cancer Center / University of Arizona Tucson, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
View all 48 locations
View Trial Details

Related conditions